Self-emulsifying formulation of bisphosphonates and associated dosage forms
US11173169B2 · kind B2 · utility
0Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2016 |
| Grant date | Nov 16, 2021 |
| Priority date | — |
| Expiry date | Oct 25, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The patent discloses self-emulsifying formulations of bisphosphonates or bisphosphonic acids in the prevention and treatment of conditions involving calcium or phosphate metabolism. The dosage forms are either capsules, or tablets, or other controlled release drug delivery systems, or devices that contain self-emulsifying formulation of such bisphosphonates or bisphosphonic acids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.